Your Source for Venture Capital and Private Equity Financings

Select An Article

Avoca Raises $125M
2026-04-27
NEW YORK, NY, Avoca, the leading AI platform for America's services economy, announced it has raised more than $125 million across Seed, Series A, and Series B funding.
Read More
Orkes Inks $60M Series B Financing
2026-04-27
SANTA CLARA, CA, Orkes, the agents and durable workflow orchestration platform, has raised a $60 million Series B round led by AVP.
Read More
Serif Biomedicines Raises $50 Million
2026-04-27
CAMBRIDGE, MA, Flagship Pioneering, a scientific innovation engine for transformative platforms and products, announced the launch of Serif Biomedicines, a biotechnology company pioneering Modified DNA as a new class of medicines.
Read More
TriFetch Scores $1.9M Pre-Seed Round
2026-04-27
SAN FRANCISCO, CA, TriFetch announced a $1.9 million pre-seed round led by Nexus Venture Partners with participation from angels.
Read More
Nervonik Announces $52.5M Series B Financing
2026-04-27
LOS ANGELES, CA, Nervonik, Inc., a clinical-stage medical device company, announced the closing of a $52.5 million Series B financing led by Amzak Health.
Read More
Fathom Therapeutics Scores $47 Million Series A
2026-04-27
NEW YORK, NY, Fathom Therapeutics, formerly Atommap Corp., a company that uses quantum chemistry and AI to design novel drug molecules by predicting their behavior inside living cells, announced an oversubscribed $47 million Series A financing.
Read More
Betterness Closes $2.5M Seed Round
2026-04-27
MIAMI, FL, Betterness, the Augmented Wellness platform building agent-first infrastructure for the health and wellness industry, announced the closing of its $2.5M seed round.
Read More
Fathom Therapeutics Scores $47 Million Series A
2026-04-27
NEW YORK, NY, Fathom Therapeutics, formerly Atommap Corp., a company that uses quantum chemistry and AI to design novel drug molecules by predicting their behavior inside living cells, announced an oversubscribed $47 million Series A financing.
Read More